Strong foundations, exceptional results
Upstream bioprocessing and downstream bioanalytical testing.
Leverage our team's expertise and dedication at our booth and explore how our comprehensive bioprocessing and bioanalytical solutions can enhance the safety and quality of your therapeutic development. We'll be featuring our innovative platforms and products across::
- Cell line development and engineering
- Cell culture and upstream processing
- Analytical, quality, and characterization
- Cell and gene therapy
Join Revvity at BPS 2025 in Boston - Booth #504
Discover bioprocessing solutions that help you own your biotherapeutic process and deliver with confidence.
For research use only. Not for use in diagnostic procedures.
The CHOSOURCE™ Platform technology is available for research, clinical, diagnostic, and commercialization applications, including services, under specific licenses from Revvity.
LentiBOOST™ GMP Grade technology: Not for Diagnostic Use. Other applications must be authorized by a license from Revvity.
A commercial license is required for any clinical or commercial application involving AAVs developed using Revvity technologies.
HEKcellence and Vectonize are available for research, clinical, and commercialization applications, including services, under specific limited licenses from Revvity.
Revvity at BPS Annual Meeting 2025
Analytical, quality and characterization
What's new
HostDetect™ PCR DNA Quant Kits
These real-time PCR assays (RUO) enable quantitative detection of residual HEK293, CHO, or E. coli host genomic DNA in extracted nucleic acid samples from biopharmaceutical products.
LabChip™ Plasmid DNA (pDNA) Assay
The LabChip™ Plasmid DNA assay is designed to streamline your plasmid (pDNA) workflows. It separates the three primary isoforms of pDNA in under 2 minutes/sample while providing purity assessment based on the corrected area percentages for each conformation.
pHSense reagents
pHSense™ probes are plate reader-compatible reagents specifically developed for internalization studies using a time-resolved fluorescence (TRF) readout. Fully compatible with our MLD platforms, pHSense enables sensitive, quantitative detection of internalization events in a high-throughput, plate-based format.
HEKcellence™ expression platform
We're looking for some most HEKcellent beta testers for this adaptable HEK293 expression system. It can produce higher quality vectors by increasing the proportion with full payloads, providing a route to lower dose requirements and ultimately reduced treatment costs and improved drug safety profiles.
Vectonize™ transgene suppression platform
Overcome production issues with our new Vectonize transgene suppression technology that prevents expression of your target sequence during production, improving or even enabling production of interfering protein payloads. Join our beta program for first access.
Scientific presentations
Gene editing in biotherapeutic cell lines: transformative possibilities, technical considerations
Speaker: Austin Hallgren
Session: Cell line engineering and development
Date: Tuesday August 19, 2025
Time: 12:45 PM – 1:00 PM
Abstract: This seminar addresses how strategic cell line engineering can overcome fundamental challenges in biotherapeutic production, where manufacturing cell lines aren't inherently optimized for complex protein expression. We'll examine gene editing applications in bioprocess host cell lines that address protein quality and cell growth characteristics. The presentation will navigate the often-understated technical complexities of cell line engineering, including tool selection, IP considerations, and regulatory requirements. Join us to discover how Revvity's Cell Line Engineering capabilities can transform your biotherapeutic development from concept to commercial production.
Posters
Analytical methods to evaluate RNA circularization efficiency
Session: C7A: RNA Development, CMC, and Manufacturing
Date: Monday August 18 – Tuesday August 19
Time: During refreshment breaks
Where: Exhibit hall
Application of gene editing technologies to improve biotherapeutic manufacturing
Session: C1A: Cell Line Engineering & Development
Date: Monday August 18 – Tuesday August 19
Time: During refreshment breaks
Where: Exhibit hall
Plasmid purity testing and conformational analysis using the LabChip™ GX Touch platform
Session: C4B: Next Generation Analytical Methods
Date: Wednesday August 20 – Thursday August 21
Time: During refreshment breaks
Where: Exhibit hall
